Strata Critical Medical (NASDAQ:SRTA) CAO Amir Cohen Sells 4,655 Shares

Strata Critical Medical (NASDAQ:SRTA) CAO Amir Cohen sold 4,655 shares of the firm’s stock in a transaction dated Monday, June 8th. The stock was sold at an average price of $5.87, for a total transaction of $27,324.85. Following the completion of the sale, the chief accounting officer owned 146,608 shares of the company’s stock, valued at $860,588.96. This trade represents a 3.08% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Amir Cohen also recently made the following trade(s):

• On Friday, May 22nd, Amir Cohen sold 40,575 shares of Strata Critical Medical stock. The stock was sold at an average price of $5.91, for a total transaction of $239,798.25.
• On Thursday, May 21st, Amir Cohen sold 10,300 shares of Strata Critical Medical stock. The stock was sold at an average price of $5.79, for a total transaction of $59,637.00.

Strata Critical Medical Price Performance

SRTA traded down $0.13 on Wednesday, hitting $5.48. The company had a trading volume of 1,306,562 shares, compared to its average volume of 874,584. Strata Critical Medical has a 52-week low of $3.57 and a 52-week high of $6.50. The business has a fifty day simple moving average of $5.14. The firm has a market cap of $474.18 million, a price-to-earnings ratio of -68.50 and a beta of 2.20.

Strata Critical Medical (NASDAQ:SRTA) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $0.03 EPS for the quarter, topping the consensus estimate of ($0.04) by $0.07. Strata Critical Medical had a net margin of 20.56% and a negative return on equity of 4.06%. The business had revenue of $67.38 million during the quarter. On average, analysts anticipate that Strata Critical Medical will post -0.14 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the stock. Weiss Ratings raised shares of Strata Critical Medical from a “hold (c-)” rating to a “hold (c)” rating in a research note on Monday, May 11th. Zacks Research raised shares of Strata Critical Medical to a “hold” rating in a research note on Thursday, March 26th. Craig Hallum assumed coverage on shares of Strata Critical Medical in a research note on Wednesday, March 25th. They set a “buy” rating and a $8.00 target price for the company. Finally, B. Riley Financial assumed coverage on shares of Strata Critical Medical in a research note on Wednesday, March 25th. They set a “buy” rating and a $8.00 target price for the company. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $8.00.

Institutional Investors Weigh In On Strata Critical Medical

Several institutional investors and hedge funds have recently made changes to their positions in SRTA. Dimensional Fund Advisors LP increased its position in shares of Strata Critical Medical by 11.9% during the first quarter. Dimensional Fund Advisors LP now owns 1,617,104 shares of the company’s stock valued at $6,759,000 after acquiring an additional 172,154 shares in the last quarter. Principal Financial Group Inc. bought a new stake in shares of Strata Critical Medical during the first quarter valued at approximately $537,000. Quantinno Capital Management LP increased its position in shares of Strata Critical Medical by 98.7% during the first quarter. Quantinno Capital Management LP now owns 143,239 shares of the company’s stock valued at $599,000 after acquiring an additional 71,155 shares in the last quarter. Bank of America Corp DE increased its position in shares of Strata Critical Medical by 16.2% during the first quarter. Bank of America Corp DE now owns 181,574 shares of the company’s stock valued at $759,000 after acquiring an additional 25,379 shares in the last quarter. Finally, Granite Investment Partners LLC increased its position in shares of Strata Critical Medical by 77.0% during the first quarter. Granite Investment Partners LLC now owns 18,181 shares of the company’s stock valued at $76,000 after acquiring an additional 7,911 shares in the last quarter. Institutional investors own 47.36% of the company’s stock.

Strata Critical Medical Company Profile

Blade Air Mobility, Inc provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.